GUARDION HEALTH SCIENCES INC (GHSI)
US40145Q5009 - Common Stock
Overall GHSI gets a fundamental rating of 4 out of 10. We evaluated GHSI against 37 industry peers in the Personal Care Products industry. No worries on liquidiy or solvency for GHSI as it has an excellent financial health rating, but there are worries on the profitability. GHSI is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year GHSI was profitable.
In the past year GHSI has reported a negative cash flow from operations.
GHSI had negative earnings in 4 of the past 5 years.
GHSI had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.30%, GHSI is in line with its industry, outperforming 48.65% of the companies in the same industry.
Looking at the Return On Equity, with a value of 1.90%, GHSI is in line with its industry, outperforming 54.05% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.3% | ||
| ROE | 1.9% | ||
| ROIC | N/A |
ROA(3y)-59.1%
ROA(5y)-69.74%
ROE(3y)-76.49%
ROE(5y)-84.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of GHSI (1.26%) is comparable to the rest of the industry.
GHSI's Gross Margin of 44.06% is on the low side compared to the rest of the industry. GHSI is outperformed by 64.86% of its industry peers.
GHSI's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 1.26% | ||
| GM | 44.06% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.13%
GM growth 5Y-5.18%
2. Health
2.1 Basic Checks
GHSI does not have a ROIC to compare to the WACC, probably because it is not profitable.
GHSI has more shares outstanding than it did 1 year ago.
GHSI has more shares outstanding than it did 5 years ago.
GHSI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
Based on the Altman-Z score of -8.33, we must say that GHSI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of GHSI (-8.33) is worse than 94.59% of its industry peers.
GHSI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -8.33 |
ROIC/WACCN/A
WACC9.22%
2.3 Liquidity
A Current Ratio of 9.01 indicates that GHSI has no problem at all paying its short term obligations.
The Current ratio of GHSI (9.01) is better than 97.30% of its industry peers.
A Quick Ratio of 6.98 indicates that GHSI has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 6.98, GHSI belongs to the best of the industry, outperforming 94.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 9.01 | ||
| Quick Ratio | 6.98 |
3. Growth
3.1 Past
GHSI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.69%, which is quite impressive.
The Revenue has grown by 10.91% in the past year. This is quite good.
GHSI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 67.11% yearly.
EPS 1Y (TTM)100.69%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q104.21%
Revenue 1Y (TTM)10.91%
Revenue growth 3Y86.44%
Revenue growth 5Y67.11%
Revenue growth Q2Q7.54%
3.2 Future
The Earnings Per Share is expected to decrease by -110.23% on average over the next years. This is quite bad
Based on estimates for the next years, GHSI will show a quite strong growth in Revenue. The Revenue will grow by 9.78% on average per year.
EPS Next Y-669.3%
EPS Next 2Y-110.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.56%
Revenue Next 2Y9.78%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 18.60, the valuation of GHSI can be described as rather expensive.
Based on the Price/Earnings ratio, GHSI is valued a bit cheaper than the industry average as 72.97% of the companies are valued more expensively.
GHSI is valuated rather cheaply when we compare the Price/Earnings ratio to 28.28, which is the current average of the S&P500 Index.
The Forward Price/Earnings Ratio is negative for GHSI. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.6 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
GHSI's earnings are expected to decrease with -110.23% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-110.23%
EPS Next 3YN/A
5. Dividend
5.1 Amount
GHSI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
GUARDION HEALTH SCIENCES INC
NASDAQ:GHSI (5/3/2024, 7:00:01 PM)
8
-0.14 (-1.72%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap10.24M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.6 | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.3% | ||
| ROE | 1.9% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | 1.26% | ||
| GM | 44.06% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.03
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 9.01 | ||
| Quick Ratio | 6.98 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)100.69%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-669.3%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)10.91%
Revenue growth 3Y86.44%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y